Miltefosin Or Perifosin For Use In The Treatment of IBD
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 10, 2016
app pub date -
Apr 8, 2014
filing date -
Apr 8, 2013
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance
Loading Importance Indicators...

Calculated Rating
US Family Size
|
Non-US Coverage
|
Abstract
Miltefosin or perifosin for use in the treatment or prevention of inflammatory bowel disease (IBD).
First Claim
all claims..Other Claims data not available
Family
+
−
Country | kind | publication No. | Filing Date | Type | Sub-Type |
---|---|---|---|---|---|
JP | A | JP2016515602 | Apr 08, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
Published unexamined patent application | IBDの治療に使用するためのミルテホシンまたはペリホシン | May 30, 2016 | |||
EP | A1 | EP2983709 | Apr 08, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
APPLICATION PUBLISHED WITH SEARCH REPORT | MILTEFOSIN OR PERIFOSIN FOR USE IN THE TREATMENT OF IBD | Feb 17, 2016 | |||
WO | A1 | WO2014166941 | Apr 08, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT | MILTEFOSIN OR PERIFOSIN FOR USE IN THE TREATMENT OF IBD | Oct 16, 2014 |
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
ACADEMISCH ZIEKENHUIS LEIDEN H O D N | LEIDEN |
International Classification(s)

- 2014 Application Filing Year
- A61K Class
- 14144 Applications Filed
- 11600 Patents Issued To-Date
- 82.02 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Van, Den Brink Gijs R | Abcoude, NL | 1 | 2 |
# of filed Patents : 1 Total Citations : 2 | |||
Verhaar, Auke | Gouda, NL | 5 | 18 |
# of filed Patents : 5 Total Citations : 18 |
Cited Art Landscape
- No Cited Art to Display
Loading Cited Art Landscape... 

Patent Citation Ranking
- 2 Citation Count
- A61K Class
- 38.16 % this patent is cited more than
- 9 Age
Forward Cite Landscape
- No Forward Cites to Display
Loading Forward Cite Landscape... 

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Sep 10, 2027 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text
US Patent Application No: 2016/0067,269
Miltefosin Or Perifosin For Use In The Treatment of IBD
Abstract
Miltefosin or perifosin for use in the treatment or prevention of inflammatory bowel disease (IBD).
Description
Claims
Claims data not available

Legal Events
- No Legal Status data available.

Matter Detail

Country:
Application No:
Patent No:
Application Publication No:
Status:
Priority Date:
Filing Date:
Matter Type:
Local Registration No:
Docket No:
Secondary System Identifier (SSI):
Customer Application No:
Filing Type:
Request for Examination Date:
Parent Filing Date:
Complete Specification Date:
PCT Filing Date:
National Entry Date:
First Publication Date:
Allowance Date:
Grant Date:
Grant Publication Date:
Claims:
Independent Claims:
Law Firm:
Renewals Detail

Applicant:
Applicant ID:
Entity Size:
Renewal Status:
Renewal Base Date:
Renewal Trigger Date: